NCT06077019View on ClinicalTrials.gov

Role of Lung Function for Exercise Capacity in Well-trained Individuals

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

July 15, 2026

Study Completion Date

December 1, 2026

Conditions
Exercise Performance
Interventions
DRUG

Vilanterol and Fluticasone Furoate

Participants inhale 25 µg vilanterol + fluticasone furoate daily

DRUG

Indacaterol and Mometasone Furoate

Participants inhale 125 µg indacaterol + mometasone furoate daily

DRUG

Placebo

Participants inhale placebo daily

Trial Locations (1)

2100

RECRUITING

August Krogh Building, Copenhagen

All Listed Sponsors
lead

Morten Hostrup, PhD

OTHER